Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Retained earnings (deficit)
Total
Beginning Balances at Dec. 31, 2019 $ 35 $ 6,682 $ 3,348 $ 10,065
Beginning Balances (in shares) at Dec. 31, 2019 34,795,313      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation   368   368
Expected tax loss of future stock compensation option exercises   (288)   (288)
Equity component of convertible debt issuance   1,220   1,220
Fair value of finders' warrants   46   46
Net loss     (13,744) (13,744)
Ending Balance at Jun. 30, 2020 $ 35 8,028 (10,396) (2,333)
Ending Balance (in shares) at Jun. 30, 2020 34,795,313      
Beginning Balances at Dec. 31, 2019 $ 35 6,682 3,348 10,065
Beginning Balances (in shares) at Dec. 31, 2019 34,795,313      
Ending Balance at Dec. 31, 2020 $ 56 30,841 (11,688) 19,209
Ending Balance (in shares) at Dec. 31, 2020 56,378,939      
Beginning Balances at Mar. 31, 2020 $ 35 7,500 2,934 10,469
Beginning Balances (in shares) at Mar. 31, 2020 34,795,313      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation   163   163
Expected tax loss of future stock compensation option exercises   (115)   (115)
Equity component of convertible debt issuance   466   466
Fair value of finders' warrants   14   14
Net loss     (13,330) (13,330)
Ending Balance at Jun. 30, 2020 $ 35 8,028 (10,396) (2,333)
Ending Balance (in shares) at Jun. 30, 2020 34,795,313      
Beginning Balances at Dec. 31, 2020 $ 56 30,841 (11,688) 19,209
Beginning Balances (in shares) at Dec. 31, 2020 56,378,939      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common share issuance, net $ 2 2,455   2,457
Common share issuance, net (in shares) 2,018,924      
Stock-based compensation   607   607
Equity component of convertible debt issuance   1,204   1,204
Settlement of performance share liability   2,293   2,293
Settlement of performance share liability (in shares) 294,838      
Net loss     (2,538) (2,538)
Ending Balance at Jun. 30, 2021 $ 58 37,400 (14,226) 23,232
Ending Balance (in shares) at Jun. 30, 2021 58,692,701      
Beginning Balances at Mar. 31, 2021 $ 56 31,707 (12,919) 18,844
Beginning Balances (in shares) at Mar. 31, 2021 56,598,777      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common share issuance, net $ 2 2,455   2,457
Common share issuance, net (in shares) 2,018,924      
Stock-based compensation   327   327
Equity component of convertible debt issuance   1,204   1,204
Settlement of performance share liability   1,707   1,707
Settlement of performance share liability (in shares) 75,000      
Net loss     (1,307) (1,307)
Ending Balance at Jun. 30, 2021 $ 58 $ 37,400 $ (14,226) $ 23,232
Ending Balance (in shares) at Jun. 30, 2021 58,692,701